Home/ Supplements/ Berberine/ Berberine Phytosome+

Berberine Phytosome+

product on market Capsule Codeage Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Berberine phytosome is designed to enhance the bioavailability of berberine, which has strong evidence for supporting healthy blood glucose levels and metabolic function. Research indicates it may improve insulin sensitivity and lipid profiles. The evidence for these metabolic effects is generally considered strong across multiple clinical studies.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Berberine Phytosome+
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 500.0mg (234 products) 95 studies (A:0, B:35)

Other Ingredients

Methylcellulose
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: Adults take 1 capsule daily, or as recommended your by healthcare practitioner, with 8 ounces of water or your favorite beverage. May betaken with or without food.

Warnings & Precautions

Caution: As with any dietary supplement, consult your healthcare practitioner before using this product, especially if you are pregnant, nursing, or are otherwise under medical supervision.

Discontinue use two weeks prior to surgery.

Please use caution if you have allergies or sensitivities to any of the listed ingredients.

Not intended for those under the age of 18. Keep out of reach of children and pets.

Do not use if product has been opened or tampered with in any way.

Formulation Notes

Bioavailable Berberine Essential Phospholipids Alpha Lipoic Acid

Vegan

Non-GMO Soy-Free Dairy-Free Gluten-Free

cGMP Certified Manufacturing

Alpha Lipoic Acid Phospholipid Complex

Bioavailable

Additional Information

2-Month Supply

Please recycle Bottle & Cap Please take off the label Questions? Codeage.com Scan for info

Store in a cool, dry place.

Feel Different.

Metadata

Product Details

UPC / SKU8 50049 60926 5
DSLD Entry Date2025-05-21
Product TypeOther Combinations
FormCapsule
BrandCodeage
DSLD ID333404
Data Updated2026-04-11
Research

Research Evidence

98
Research Sources
55
Avg Quality
48
Systematic Review
39
Meta Analysis
4
Rct
4
Clinical Trial
1
Other
1
Narrative Review
1
Openfda Safety
B Efficacy and safety of berberine for dyslipidaemias: A systematic review and meta-analysis of randomized clinical trials
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2018 PubMed DOI
B Effects berberine-silymarin on liver enzymes: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Clinical nutrition ESPEN 2022 PubMed DOI
B Efficacy and safety of berberine for several cardiovascular diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2023 PubMed DOI
B Effect of Berberine on C-reactive protein: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Complementary therapies in medicine 2019 PubMed DOI
B Overall and Sex-Specific Effect of Berberine on Glycemic and Insulin-Related Traits: a Systematic Review and Meta-Analysis of Randomized Controlled Trials
Meta Analysis The Journal of nutrition 2023 PubMed DOI
B The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review
Meta Analysis Journal of translational medicine 2024 PubMed DOI
B Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Clinical and Pre-Clinical Overview and Systematic Review of the Literature
Systematic Review International journal of molecular sciences 2024 PubMed DOI
B Efficacy and Safety of Berberine Alone or Combined with Statins for the Treatment of Hyperlipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis The American journal of Chinese medicine 2019 PubMed DOI
B Effects of Berries, Phytochemicals, and Probiotics on Atherosclerosis through Gut Microbiota Modification: A Meta-Analysis of Animal Studies
Meta Analysis International journal of molecular sciences 2023 PubMed DOI
B Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes: A Randomized Clinical Trial
Rct JAMA network open 2025 PubMed DOI
View all evidence for Berberine →
Compare

Similar Products

View all Berberine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.